Financials data is unavailable for this security.
View more
Year on year Globus Medical Inc had net income fall -35.39% from 190.17m to 122.87m despite a 53.34% increase in revenues from 1.02bn to 1.57bn. An increase in the cost of goods sold as a percentage of sales from 25.78% to 34.95% was a component in the falling net income despite rising revenues.
| Gross margin | 58.14% |
|---|---|
| Net profit margin | 3.69% |
| Operating margin | 4.67% |
| Return on assets | 1.75% |
|---|---|
| Return on equity | 2.22% |
| Return on investment | 1.99% |
More ▼
Cash flow in USDView more
In 2023, Globus Medical Inc increased its cash reserves by 210.56%, or 316.83m. Cash Flow from Investing totalled 302.97m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 243.50m in cash from operations while cash used for financing totalled 231.82m.
| Cash flow per share | 2.55 |
|---|---|
| Price/Cash flow per share | 38.50 |
| Book value per share | 29.94 |
|---|---|
| Tangible book value per share | 13.21 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.51 |
|---|---|
| Quick ratio | 1.64 |
| Total debt/total equity | 0.1079 |
|---|---|
| Total debt/total capital | 0.0974 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -42.14%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| EPS growth(5 years) | -7.04 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -57.08 |
